BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 30348117)

  • 21. p53-dependent non-coding RNA networks in chronic lymphocytic leukemia.
    Blume CJ; Hotz-Wagenblatt A; Hüllein J; Sellner L; Jethwa A; Stolz T; Slabicki M; Lee K; Sharathchandra A; Benner A; Dietrich S; Oakes CC; Dreger P; te Raa D; Kater AP; Jauch A; Merkel O; Oren M; Hielscher T; Zenz T
    Leukemia; 2015 Oct; 29(10):2015-23. PubMed ID: 25971364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway.
    Wang LQ; Kwong YL; Kho CS; Wong KF; Wong KY; Ferracin M; Calin GA; Chim CS
    Mol Cancer; 2013 Dec; 12():173. PubMed ID: 24373626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
    Zhu DX; Miao KR; Fang C; Fan L; Zhu W; Zhu HY; Zhuang Y; Hong M; Liu P; Xu W; Li JY
    Leuk Res; 2011 Jun; 35(6):730-4. PubMed ID: 21130495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
    Bomben R; Dal-Bo M; Benedetti D; Capello D; Forconi F; Marconi D; Bertoni F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Luciano F; Sozzi E; Cattarossi I; Zucchetto A; Rossi FM; Bulian P; Zucca E; Nicoloso MS; Degan M; Marasca R; Efremov DG; Del Poeta G; Gaidano G; Gattei V
    Clin Cancer Res; 2010 Jan; 16(2):620-8. PubMed ID: 20068100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
    Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
    Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways.
    Wang LQ; Wong KY; Rosèn A; Chim CS
    Oncotarget; 2015 Dec; 6(42):44422-36. PubMed ID: 26517243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies
    Rani L; Mathur N; Gupta R; Gogia A; Kaur G; Dhanjal JK; Sundar D; Kumar L; Sharma A
    Clin Epigenetics; 2017; 9():57. PubMed ID: 28572861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant expression profile of miR-32, miR-98 and miR-374 in chronic lymphocytic leukemia.
    Rahimi Z; Ghorbani Z; Motamed H; Jalilian N
    Leuk Res; 2021 Dec; 111():106691. PubMed ID: 34455196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of down-regulated cylindromatosis gene in chronic lymphocytic leukemia.
    Wu W; Zhu H; Fu Y; Shen W; Xu J; Miao K; Hong M; Xu W; Liu P; Li J
    Leuk Lymphoma; 2014 Mar; 55(3):588-94. PubMed ID: 23725390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.
    Wang LQ; Kwong YL; Wong KF; Kho CS; Jin DY; Tse E; Rosèn A; Chim CS
    J Transl Med; 2014 Feb; 12():52. PubMed ID: 24559316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased chronic lymphocytic leukemia proliferation upon IgM stimulation is sustained by the upregulation of miR-132 and miR-212.
    Tavolaro S; Colombo T; Chiaretti S; Peragine N; Fulci V; Ricciardi MR; Messina M; Bonina S; Brugnoletti F; Marinelli M; Di Maio V; Mauro FR; Del Giudice I; Macino G; Foà R; Guarini A
    Genes Chromosomes Cancer; 2015 Apr; 54(4):222-34. PubMed ID: 25645730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia.
    Fabbri M; Bottoni A; Shimizu M; Spizzo R; Nicoloso MS; Rossi S; Barbarotto E; Cimmino A; Adair B; Wojcik SE; Valeri N; Calore F; Sampath D; Fanini F; Vannini I; Musuraca G; Dell'Aquila M; Alder H; Davuluri RV; Rassenti LZ; Negrini M; Nakamura T; Amadori D; Kay NE; Rai KR; Keating MJ; Kipps TJ; Calin GA; Croce CM
    JAMA; 2011 Jan; 305(1):59-67. PubMed ID: 21205967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA expression in chronic lymphocytic leukemia developing autoimmune hemolytic anemia.
    Ferrer G; Navarro A; Hodgson K; Aymerich M; Pereira A; Baumann T; Monzo M; Moreno C; Montserrat E
    Leuk Lymphoma; 2013 Sep; 54(9):2016-22. PubMed ID: 23286334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of LPL gene expression in patients with chronic lymphocytic leukemia.
    Bilous N; Abramenko I; Chumak A; Dyagil I; Martina Z
    Exp Oncol; 2019 Mar; 41(1):39-45. PubMed ID: 30932419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia.
    Maura F; Cutrona G; Mosca L; Matis S; Lionetti M; Fabris S; Agnelli L; Colombo M; Massucco C; Ferracin M; Zagatti B; Reverberi D; Gentile M; Recchia AG; Bossio S; Rossi D; Gaidano G; Molica S; Cortelezzi A; Di Raimondo F; Negrini M; Tassone P; Morabito F; Ferrarini M; Neri A
    Leuk Lymphoma; 2015; 56(11):3150-8. PubMed ID: 25860243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1.
    Mraz M; Chen L; Rassenti LZ; Ghia EM; Li H; Jepsen K; Smith EN; Messer K; Frazer KA; Kipps TJ
    Blood; 2014 Jul; 124(1):84-95. PubMed ID: 24787006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Detection of puma mRNA levels by real-time quantitative RT-PCR in chronic lymphocytic leukemia and its clinical significance].
    Zhu HJ; Xu W; Cao X; Fang C; Zhu DX; Dong HJ; Wang DM; Qiao C; Miao KR; Liu P; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):843-8. PubMed ID: 20723285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of microRNA-454 impedes the proliferation and invasion of prostate cancer cells by promoting N-myc downstream-regulated gene 2 and inhibiting WNT/β-catenin signaling.
    Fu Q; Gao Y; Yang F; Mao T; Sun Z; Wang H; Song B; Li X
    Biomed Pharmacother; 2018 Jan; 97():120-127. PubMed ID: 29080452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters.
    Negrini M; Cutrona G; Bassi C; Fabris S; Zagatti B; Colombo M; Ferracin M; D'Abundo L; Saccenti E; Matis S; Lionetti M; Agnelli L; Gentile M; Recchia AG; Bossio S; Reverberi D; Rigolin G; Calin GA; Sabbioni S; Russo G; Tassone P; Morabito F; Ferrarini M; Neri A
    Clin Cancer Res; 2014 Aug; 20(15):4141-53. PubMed ID: 24916701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.